Maarten R Seefat
6PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 10, 2025
Uncovering the ultra-frail: A distinct subgroup in non-transplant eligible newly diagnosed patients with multiple myeloma, with an inferior clinical outcome.Kazimierz Groen, Febe Smits, Kazem Nasserinejad
|Nov 03, 2025
Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myeloma.M R Seefat, D G J Cucchi, L van Boven
|Aug 22, 2025
Frail subgroups determine heterogeneous outcomes in older patients with NDMM: long-term follow-up of the HOVON 143 trial.Febe Smits, Kaz Groen, Mark-David Levin
|Nov 22, 2024
Beyond static measurements: dynamic frailty improves survival prediction in multiple myeloma.Febe Smits, Kaz Groen, Mark-David Levin
|Oct 11, 2023
Treatment sequences and drug costs from diagnosis to death in multiple myeloma.M R Seefat, D G J Cucchi, K Groen
|Nov 27, 2021
A Systematic Review of Cost-Effectiveness Analyses of Novel Agents in the Treatment of Multiple Myeloma.Maarten R Seefat, David G J Cucchi, Stijn Dirven
Pageof 1
Frequent Collaborators
3 joint publications
Sonja Zweegman
2 joint publications
David G J Cucchi
2 joint publications
Niels W C J van de Donk
2 joint publications
Hedwig M Blommestein
2 joint publications
Mark-David Levin
2 joint publications
Yorick Sandberg
2 joint publications
Alain Kentos
2 joint publications
Nicole C H P de Graauw
1 joint publications
C L B M Korst
1 joint publications
R Mathot
